SynthesisGut and liver2026
Risk of Gastric Neoplasms in Patients with Autoimmune Gastritis: A Systematic Review and Meta-Analysis.
Synthesis in Gut and liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Evolution of Autoimmune Gastritis Research (1995-2025): A Hybrid Bibliometric-Conceptual Synthesis.The Korean journal of helicobacter and upper gastrointestinal research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: Autoimmune gastritis (AIG) underlies type 1 gastric neuroendocrine tumors (NETs) and pernicious anemia (PA), a late-stage manifestation of AIG. Although PA is a risk factor for gastric cancer (GC), the independent neoplastic risk of AIG and the modifying role of Methods: A PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-guided systematic review and meta-analysis were performed. PubMed, EMBASE, and the Cochrane Library were searched for studies of gastric neoplasms in adults with AIG or PA. Pooled incidence rates and risk estimates were calculated. Between-study heterogeneity was explored by using meta-regression. Publication bias, sensitivity, and Results: In patients with AIG, pooled incidence rates (per 1,000 person-years) were 2.08 for GC, 5.35 for dysplasia, and 14.56 for NETs. The GC incidence was not statistically significant overall but became significant in sensitivity analyses when the Rugge Conclusions: AIG was associated with increased risks of dysplasia and NETs, and GC risk might be underestimated in the presence of substantial heterogeneity. PA was associated with a higher risk of GC. Endoscopic surveillance may be considered in patients with AIG, particularly for dysplasia, NET, and GC risks in those with concomitant PA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.